Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT(1A) receptor antagonists

European Journal of Pharmacology

Volumn 357, Issue 2-3, 1998, Pages 179-184

  Trillat, Anne Cécile ^a   Malagié, Isabelle ^a   Mathe Allainmat, Monique ^a,b   Anmella, Marie Claude ^a   Jacquot, Christian ^a   Langlois, Michel ^a,b   Gardier, Alain M ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITÉ PARIS SUD   (France)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

( ) 5 Me 8 OH DPAT(( ) 5 methyl 8 hydroxy 2 (di n propylamino)tetralin); 5 HT(1A) receptor; Fluoxetine; Food intake; Microdialysis; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 5 METHYLTETRALIN; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; FOOD INTAKE; FRONTAL CORTEX; HIPPOCAMPUS; HYPOPHAGIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032544772     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00590-1     Document Type: Article

References (33)

1. Auerbach S.B., Lundberg J.F., Hjorth S. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology. 34:1995;89-96.
2. Caccia S., Bizzi A., Coltro G., Fracasso C., Frittoli E., Mennini T., Garattini S. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J. Pharm. Pharmacol. 44:1992;250-254.
3. 1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats. Psychopharmacology. 134:1997;55-63.
4. Clifton P.G., Lee M.D. Fluoxetine hypophagia. Trends Pharmacol. Sci. 18:1997;191.
5. Curzon G., Gibson E.L., Oluyomi A.O. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol. Sci. 18:1997;21-25.
6. Dailey J.W., Yan Q.S., Mishra P.K., Burger R.L., Jobe P.C. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J. Pharmacol. Exp. Ther. 260:1992;533-540.
7. Dourish C.T., Hutson P.H., Curzon G. Low doses of the putative serotonin agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology. 86:1985;197-204.
8. 1A receptors. Neurochem. Res. 21:1996;557-562.
9. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with S-WAY-100135. J. Pharmacol. Exp. Ther. 278:1996;752-762.
10. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
11. Fuller R.W., Perry K.W., Hemrick-Luecke S.K., Engleman E. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus. J. Pharm. Pharmacol. 48:1996;68-70.
12. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1995;1064-1070.
13. Gobert A., Rivet J-M., Cistarelli L., Millan M.J. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. J. Neurochem. 68:1997;1326-1329.
14. Goudie A.J., Thornton E.W., Wheeler T.J. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding. J. Pharm. Pharmacol. 28:1976;318-320.
15. Hjorth S. (-)-Pinbutolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol. 303:1996;183-186.
16. Hoebel, B., Schwartz, D., West, H.L., Mark, G.P., Hernandez, L., 1991. Serotonin microdialysis in the hypothalamus during feeding, learned taste aversion, fluoxetine, fenfluramine and tryptophan. In: Rollema, H., Westerink, B.W.J. (Eds.), Monitoring Molecules in Neuroscience. Groningen, pp. 212-215.
17. 3H ]imipramine localization and relationship to serotonin transporter J. Pharmacol. Exp. Ther. 252:1990;410-418.
18. Hutson P.H., Dourish C.T., Curzon G. Neurochemical and behavioral evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur. J. Pharmacol. 129:1986;347-352.
19. Ichikawa J., Meltzer H.Y. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur. J. Pharmacol. 281:1995;255-261.
20. Li D.L., Simmons R.M.A., Iyengar S. 5-HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding. Brain Res. 781:1998;121-128.
21. Lightowler S., Wood M., Brown T., Alison G., Blackburn T., Tulloch I., Kennett G. An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats. Eur. J. Pharmacol. 296:1996;137-143.
22. Malagié I., Trillat A-C., Jacquot C., Gardier A.M. Effects of acute fluoxetine on extracellular serotonin concentrations in the raphé: an in vivo microdialysis study. Eur. J. Pharmacol. 286:1995;213-217.
23. Malagié I., Trillat A-C., Douvier E., Anmella M-C., Dessalles M-C., Jacquot C., Gardier A.M. Regional differences in the effect of the combine treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;785-790.
24. Molina V., Ciesielski L., Gobaille S., Isel F., Mandel P. Inhibition of mouse killing behavior by serotonin-mimetic drugs: effects of partial alterations of serotonin neurotransmission. Pharmacol. Biochem. Behav. 27:1987;123-131.
25. O'Connell M.T., Curzon G. A comparison of the effects of 8-OH-DPAT pretreatment on different behavioural responses to 8-OH-DPAT. Eur. J. Pharmacol. 312:1996;137-143.
26. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando, FL.
27. Perry K.W., Fuller R.W. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophane. J. Pharm. Pharmacol. 45:1993;759-761.
28. Romero L., Artigas F. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway-role of somatodendritic autoreceptors. J. Neurochem. 68:1997;2593-2603.
29. Slater I.H., Jones G.T., Moore R.A. Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake. Neuropharmacology. 17:1978;383-389.
30. Stanford S.C. Prozac: panacea or puzzle? Trends Pharmacol. Sci. 17:1996;150-154.
31. 1A receptor antagonist, on 8-OH-DPAT responses. Eur. J. Pharmacol. 347:1998;41-49.
32. Wong D.T., Reid L.R., Threlkeld P.G. Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists. Pharmacol. Biochem. Behav. 31:1988;475.
33. Wurtman, R.J., Wurtman, J.J., 1990. Nutrition and the Brain. Raven Press, New York, NY.